Ant Group Brings Alipay+ to the Philippines with Three New Mobile Wallets, AlipayHK, Kakao Pay and Touch ‘n Go eWallet
5.9.2023 07:58:00 EEST | Business Wire | Press release
Ant Group, the operator of Alipay+, the global cross-border digital payments and marketing solution, today announced that a total of four mobile wallets are now accepted in the Philippines. These include AlipayHK (Hong Kong SAR), Kakao Pay (South Korea), Touch ‘n Go eWallet (Malaysia) and Alipay (Chinese mainland), which has been accepted by Filipino merchants since 2017. This enables travellers from these regions to enjoy a cashless experience, using just their home mobile wallets to make payment, improving the travel experience as digital payment options like mobile wallets become the norm for day-to-day transactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230904840228/en/
Mactan-Cebu International Airport, which saw 219% increase in passengers in the 1H of 2023, have integrated Alipay+ across 90% of its merchants (Photo: Business Wire)
The acceptance of three new mobile wallets, via Alipay+, comes as travellers return to the Philippines. According to the Department of Tourism (DOT), more than 3 million tourists have visited the Philippines from January 1 to July 19, 2023, reflecting continued robust recovery. The DOT also shared that inbound tourism receipts from January 1 to June 30, 2023, are more than 500% higher than the same period last year1. South Koreans top the list of international visitors to the Philippines, while Malaysia ranks in the top 102.
Alipay+ is currently accepted by merchants in Manila and Cebu, the top two most visited cities in the Philippines pre-pandemic in 20193. In the first half of 2023, Mactan-Cebu International Airport saw a 219% increase in passengers compared to the same period last year. In order to cater to the new expectations of digital-first travellers, the airport has integrated Alipay+ across 90% of its merchants, ensuring that tourists can enjoy a digitally-enhanced cashless experience from the moment they arrive in Cebu.
Athanasios Titonis, Aboitiz InfraCapital Chief Executive Officer assigned to MCIA, said: “At MCIA, we have always placed utmost importance on providing convenience and ease of travel through seamless processes and world-class services and amenities. The integration of Alipay+ gives our passengers that exceptional convenience and more payment options when they travel through MCIA.”
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines with over 11 million passengers annually, making it the second busiest airport in the country. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. To date, MCIA is the first and only airport in the Philippines to receive the Airport Customer Experience (ACX) accreditation from the Airports Council International.
Commenting on this new development, Dr. Cherry Huang, General Manager of Alipay+ Offline Merchant Services at Ant Group, said: “Philippines and its many islands, such as Cebu, have long been a favourite destination for Asian travellers and we look forward to working with our local partners to enhance their travel experience. We believe that digital adoption and solutions will shape travellers’ expectations, particularly in the way the engage travel-related businesses, from airports and hospitality to F&B and retail stores. Our focus now is to work with more partners to onboard more merchants with Alipay+ across the Philippines, particularly local small businesses, and promote digital travel and travel recovery.”
Introduced by Ant Group in 2020, Alipay+ aims to enable local businesses, especially small and medium-sized businesses, to process a wide range of mobile payment methods and reach more than 1.4 billion regional and global consumers, through one-time integration and simple technical adaption. In addition to the Philippines, Alipay+ is also widely accepted in destinations including the Chinese mainland, Macao SAR, Singapore, Thailand, Japan and South Korea among others.
About Mactan-Cebu International Airport
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines. It serves over 11 million passengers annually, making it the second busiest airline hub in the country. MCIA is operated by a Filipino-led private consortium between Aboitiz InfraCapital (AIC), GMR Group of India, and Megawide Construction Corporation (MCC), under a concession agreement with the Philippine Government. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. MCIA is accredited for the Airport Customer Experience (ACX) and the Airport Health Accreditation (AHA) by the Airports Council International.
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
Ant Group is the owner and operator of Alipay, the leading digital payment platform in China serving hundreds of millions of users, and connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services such as food delivery, transport, entertainment, and healthcare.
Ant Group has further introduced Alipay+, which provides global cross-border mobile payments and marketing solutions that connect merchant partners, especially small and medium-sized businesses, with mobile payments and other payment methods, for them to better serve their users and customers from all over the world.
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
1 Manila Bulletin (19 July 2023): PH int’l tourists breach 3M mark, revenues hit P212B
2 Department of Tourism: Tourism demand statistics 2023
3 Department of Tourism: Visitor arrivals: January – December 2019
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230904840228/en/
Contact information
Scott Lai
scott.lai@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom